Physician

Tim Mcclellan, M.D.

According to 2025 Medicare claims, Tim Mcclellan, M.D. (NPI: 1447238670) practices gastroenterology in the Wichita Falls, TX market, with the plurality of this provider's patient population coming from Wichita, TX. This provider's primary affiliated billing organization is WICHITA FALLS GASTROENTEROLOGY ASSOCIATES (NPI: 1265489298; TIN: 371521145) and primary practice location at 76301-9998. Mcclellan is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Mcclellan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 857 traditional Medicare patients, billed 8,594 HCPCS/CPT codes, and received $289,132 in Medicare payments. The top billing code was 45385 (Removal of polyps or growths of large bowel using an endoscope with mechanical snare). Part D data shows 1,399 prescription claims across 549 beneficiaries totaling $567,781 in drug costs, led by Ocaliva (Obeticholic Acid). 2018 DME data shows 24 claims. Open Payments data shows 75 records totaling $1,411. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $167,746 to $289,132. Similarly, Part D prescription costs have moved sharply higher in recent years, from $213,497 to $567,781. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	763	1,565	$167,746
2016	901	1,813	$185,645
2017	892	2,545	$184,343
2018	823	2,822	$178,305
2019	815	3,653	$238,579
2020	822	4,199	$211,765
2021	877	10,403	$323,840
2022	801	11,450	$326,678
2023	863	10,429	$318,241
2024	857	8,594	$289,132

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	283	980	$213,497
2016	393	1,185	$406,735
2017	411	1,384	$393,546
2018	454	1,436	$471,794
2019	466	1,437	$398,182
2020	450	1,568	$533,737
2021	500	1,545	$608,980
2022	499	1,462	$839,690
2023	481	1,375	$1,132,994
2024	549	1,399	$567,781

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	24	$1,744
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45385	Removal of polyps or growths of large bowel using an endoscope with mechanical snare	237	237	$197
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	291	367	$88
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	111	114	$74
99153	Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes	270	332	$8
G0500	Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito	399	417	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ocaliva	Obeticholic Acid	15	450	$138,596
Viberzi	Eluxadoline	11	320	$18,680
Sod Sulf-Potass Sulf-Mag Sulf	Sodium, Potassium,mag Sulfates	285	383	$17,453
Linzess	Linaclotide	16	840	$14,353
Dexlansoprazole Dr	Dexlansoprazole	33	1,890	$10,496

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	75	$1,411	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Tim Mcclellan, M.D.?

Tedicare shows public-source Medicare data for Tim Mcclellan, M.D. (NPI 1447238670), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Tim Mcclellan, M.D. have ACO affiliation data?

Tim Mcclellan, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Tim Mcclellan, M.D.?

Tim Mcclellan, M.D. is linked to WICHITA FALLS GASTROENTEROLOGY ASSOCIATES (billing NPI 1265489298) in the available physician profile data.

Does Tim Mcclellan, M.D. have Open Payments data?

Tim Mcclellan, M.D. has 75 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.